Transcriptional and posttranscriptional regulation of the plasminogen activator system

被引:67
作者
Nagamine, Y
Medcalf, RL
Muñoz-Cánoves, P
机构
[1] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland
[2] Monash Univ, Dept Med, Australian Ctr Blood Dis, AMREP, Prahran, Vic, Australia
[3] CRG, Programa Diferenciacio & Canc, Barcelona, Spain
关键词
review; plasminogen activator; gene regulation; mRNA stability;
D O I
10.1160/TH04-12-0814
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The core protein components of the plasminogen activator (PA) system are two plasminogen activators, two plasminogen activator inhibitors and a urokinase type plasminogen activator-specific cell surface receptor. Various types of biological regulation are exerted through the interplay of these components mutually and with extracellular matrix proteins and cell membrane proteins, with or without involving proteolytic activity. Reflecting these diverse biological roles, the level and activity of each component of the PA system is under the control of a variety of regulatory mechanisms. The expression level of a protein reflects the level of the corresponding mRNA, which is essentially the net result of de novo, synthesis, i.e. transcription, and degradation. Many recent studies have shown that the regulation of mRNA stability is dynamic and cell specific. Accordingly, we are learning that the mRNAs of the PA system are also the subject of diverse regulatory mechanisms. In this short review, we summarize current understanding of the transcriptional and mRNA-stability regulation of the PA system.
引用
收藏
页码:661 / 675
页数:15
相关论文
共 269 条
[1]   Plasminogen activator inhibitor 1, transforming growth factor-β1, and BMI are closely associated in human adipose tissue during morbid obesity [J].
Alessi, MC ;
Bastelica, D ;
Morange, P ;
Berthet, B ;
Leduc, I ;
Verdier, M ;
Geel, O ;
Juhan-Vague, I .
DIABETES, 2000, 49 (08) :1374-1380
[2]   Transactivation of the urokinase-type plasminogen activator receptor gene through a novel promoter motif bound with an activator protein-2α-related factor [J].
Allgayer, H ;
Wang, H ;
Wang, Y ;
Heiss, MM ;
Bauer, R ;
Nyormoi, O ;
Boyd, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (08) :4702-4714
[3]  
ALTUS MS, 1991, J BIOL CHEM, V266, P21190
[4]  
AMIN W, 1987, CANCER RES, V47, P6040
[5]  
Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
[6]  
2-Z
[7]   The plasminogen activation system in tumor growth, invasion, and metastasis [J].
Andreasen, PA ;
Egelund, R ;
Petersen, HH .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (01) :25-40
[8]   THE ROLE OF JUN, FOS AND THE AP-1 COMPLEX IN CELL-PROLIFERATION AND TRANSFORMATION [J].
ANGEL, P ;
KARIN, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1072 (2-3) :129-157
[9]   PHORBOL ESTER INDUCIBLE GENES CONTAIN A COMMON CIS ELEMENT RECOGNIZED BY A TPA-MODULATED TRANS-ACTING FACTOR [J].
ANGEL, P ;
IMAGAWA, M ;
CHIU, R ;
STEIN, B ;
IMBRA, RJ ;
RAHMSDORF, HJ ;
JONAT, C ;
HERRLICH, P ;
KARIN, M .
CELL, 1987, 49 (06) :729-739
[10]   Regulation of the plasminogen activator inhibitor type-2 gene in monocytes: Localization of an upstream transcriptional silencer [J].
Antalis, TM ;
Costelloe, E ;
Muddiman, J ;
Ogbourne, S ;
Donnan, K .
BLOOD, 1996, 88 (10) :3686-3697